Pulmonx Corporation

NASDAQ: LUNG · Real-Time Price · USD
1.54
0.03 (1.99%)
At close: Aug 15, 2025, 12:46 PM

Pulmonx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
83.79M 68.67M 53.66M 48.42M
Cost of Revenue
21.79M 17.92M 13.8M 12.79M
Gross Profit
62M 50.75M 39.87M 35.63M
Operating Income
-57.7M -61.94M -58.64M -47.3M
Interest Income
5.06M 5.57M 1.53M 400K
Pretax Income
-55.89M -60.27M -58.57M -48.32M
Net Income
-56.39M -60.84M -58.92M -48.66M
Selling & General & Admin
102.14M 94.61M 83.11M 69.87M
Research & Development
17.57M 18.08M 15.4M 13.06M
Other Expenses
n/a n/a -396K -585K
Operating Expenses
119.7M 112.69M 98.5M 82.93M
Interest Expense
3.51M 3.23M 1.07M 829K
Selling & Marketing Expenses
n/a 4.8M 6.1M 5.1M
Cost & Expenses
141.49M 130.61M 112.3M 95.72M
Income Tax Expense
500K 571K 353K 343K
Shares Outstanding (Basic)
39.11M 37.97M 37.1M 36.13M
Shares Outstanding (Diluted)
39.11M 37.97M 37.1M 36.13M
EPS (Basic)
-1.44 -1.6 -1.59 -1.35
EPS (Diluted)
-1.44 -1.6 -1.59 -1.35
EBITDA
-50.79M -55.09M -55.99M -46.62M
EBIT
-52.39M -57.04M -57.5M -47.49M
Depreciation & Amortization
1.59M 1.95M 4M 3.16M